Literature DB >> 29699230

Severe ovarian hyperstimulation syndrome in a 42-year-old woman with successful pregnancy after intracytoplasmic sperm injection embryo transfer.

Hiroaki Shibahara1, Kazuhiko Shimada1, Yukako Morimatsu1, Kumiko Kikuchi1, Yuki Hirano1, Tatsuya Suzuki1, Satoru Takamizawa1, Mitsuaki Suzuki1.   

Abstract

Ovarian hyperstimulation syndrome (OHSS) is an iatrogenic complication of ovulation induction for infertile women. It has been shown that patients suffering from OHSS are generally young because OHSS depends on the patient's ovarian reserve. Therefore, women ≥40 years of age seldom suffer from the severe form of OHSS. In the present study, we report a case of severe OHSS that occurred in a 42-year-old woman with a successful pregnancy after intracytoplasmic sperm injection (ICSI)-embryo transfer. She had been diagnosed as having polycystic ovary syndrome (PCOS). After 5 cycles of unsuccessful treatment with gonadotropins plus intrauterine insemination for her husband's asthenozoospermia, the treatment with assisted reproductive technology (ART) was indicated. In the third ART attempt, the patient was treated by ICSI-embryo transfer (ET) and she developed severe OHSS at 4 weeks' gestation. On admission, marked hemoconcentration, oligouria and hypo-albuminemia were diagnosed. A continuous autotransfusion system of ascites, which was developed to expand circulating plasma volume without exogenous albumin, was carried out for 5 h at a rate of 100-200 mL/h once a day for a total of 5 days. The course of the pregnancy was uneventful. At 37 weeks' gestation, a healthy baby boy weighing 3336 g was born by cesarean section when the patient was 43 years of age. The postoperative course was also uneventful. To the best of our knowledge, the present report describes the oldest woman showing severe OHSS. (Reprod Med Biol 2005; 4: 265-269).

Entities:  

Keywords:  continuous autotransfusion system of ascites; intracytoplasmic sperm injection; middle‐aged woman; ovarian hyperstimulation syndrome; polycystic ovary syndrome

Year:  2005        PMID: 29699230      PMCID: PMC5904648          DOI: 10.1111/j.1447-0578.2005.00112.x

Source DB:  PubMed          Journal:  Reprod Med Biol        ISSN: 1445-5781


  22 in total

1.  Dynamic changes of the immunoglobulins in patients with severe ovarian hyperstimulation syndrome: efficacy of a novel treatment using peritoneo-venous shunt.

Authors:  Satoru Takamizawa; Hiroaki Shibahara; Akiyo Taneichi; Hiromi Obara; Hiroyuki Fujiwara; Syuichi Ogawa; Toshimitsu Koike; Sadayoshi Idei; Ikuo Sato
Journal:  Am J Reprod Immunol       Date:  2002-01       Impact factor: 3.886

Review 2.  Ovarian hyperstimulation syndrome: a current survey.

Authors:  J G Schenker; D Weinstein
Journal:  Fertil Steril       Date:  1978-09       Impact factor: 7.329

3.  Ovarian overstimulation syndrome.

Authors:  W Z Polishuk; J G Schenker
Journal:  Fertil Steril       Date:  1969 May-Jun       Impact factor: 7.329

Review 4.  Can we eliminate severe ovarian hyperstimulation syndrome?

Authors:  Raoul Orvieto
Journal:  Hum Reprod       Date:  2004-11-26       Impact factor: 6.918

5.  Ectopic mesothelial cell proliferation in cervical lymph nodes after severe ovarian hyperstimulation syndrome.

Authors:  Robin M F van der Weiden; Carel J H Meijers; Vincent Noordhoek Hegt
Journal:  Fertil Steril       Date:  2005-03       Impact factor: 7.329

6.  Risk factors and prognostic variables in the ovarian hyperstimulation syndrome.

Authors:  D Navot; A Relou; A Birkenfeld; R Rabinowitz; A Brzezinski; E J Margalioth
Journal:  Am J Obstet Gynecol       Date:  1988-07       Impact factor: 8.661

7.  A controlled study comparing patients with and without polycystic ovaries undergoing in-vitro fertilization.

Authors:  M J MacDougall; S L Tan; A Balen; H S Jacobs
Journal:  Hum Reprod       Date:  1993-02       Impact factor: 6.918

Review 8.  Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review.

Authors:  Annick Delvigne; Serge Rozenberg
Journal:  Hum Reprod Update       Date:  2002 Nov-Dec       Impact factor: 15.610

9.  Vascular endothelial growth factor as capillary permeability agent in ovarian hyperstimulation syndrome.

Authors:  N McClure; D L Healy; P A Rogers; J Sullivan; L Beaton; R V Haning; D T Connolly; D M Robertson
Journal:  Lancet       Date:  1994-07-23       Impact factor: 79.321

10.  Plasma estradiol is superior to ultrasound and urinary estriol glucuronide as a predictor of ovarian hyperstimulation during induction of ovulation with menotropins.

Authors:  R V Haning; C W Austin; I H Carlson; D L Kuzma; S S Shapiro; W J Zweibel
Journal:  Fertil Steril       Date:  1983-07       Impact factor: 7.329

View more
  1 in total

1.  Prognostic role of follicular fluid tumor necrosis factor alpha in the risk of early ovarian hyperstimulation syndrome.

Authors:  Miaad Jabbar Alhilali; Abbas Parham; Armin Attaranzadeh; Malihe Amirian; Mohammad Azizzadeh
Journal:  BMC Pregnancy Childbirth       Date:  2020-11-12       Impact factor: 3.007

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.